Selected research
Industry Growth & Trends
Global Peptic Ulcers Treatment Industry Growth and Trends Forecast to 2032
Market perspective
The global Peptic Ulcers Treatment market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Peptic Ulcers Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Peptic Ulcers Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Peptic Ulcers Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Peptic Ulcers Treatment include Ache Laboratorios Farmaceuticos S/A, Astellas Pharma Inc., ChoDang Pharm Co., Ltd., Daewoong Pharmaceutical Co., Ltd., Kukje Pharmaceutical Industry Co., Ltd., RaQualia Pharma Inc., Sequella, Inc., Sihuan Pharmaceutical Holdings Group Ltd. and Sinil Pharmaceutical Co., Ltd, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Peptic Ulcers Treatment market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Peptic Ulcers Treatment market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Peptic Ulcers Treatment market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Peptic Ulcers Treatment.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Peptic Ulcers Treatment market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Peptic Ulcers Treatment Market by Company
Ache Laboratorios Farmaceuticos S/A
Astellas Pharma Inc.
ChoDang Pharm Co., Ltd.
Daewoong Pharmaceutical Co., Ltd.
Kukje Pharmaceutical Industry Co., Ltd.
RaQualia Pharma Inc.
Sequella, Inc.
Sihuan Pharmaceutical Holdings Group Ltd.
Sinil Pharmaceutical Co., Ltd
Yooyoung Pharmaceutical Co., Ltd
Peptic Ulcers Treatment Segment by Type
DWP-14012
DWJ-206
BGC-001
ASP-6537
Others
Peptic Ulcers Treatment Segment by Application
Hospital
Clinic
Others
Peptic Ulcers Treatment Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Peptic Ulcers Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Peptic Ulcers Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Peptic Ulcers Treatment.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Peptic Ulcers Treatment manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Peptic Ulcers Treatment in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- DWP-14012
- DWJ-206
- BGC-001
- ASP-6537
- Others
Applications
- Hospital
- Clinic
- Others
Companies covered
- Ache Laboratorios Farmaceuticos S/A
- Astellas Pharma Inc.
- ChoDang Pharm Co., Ltd.
- Daewoong Pharmaceutical Co., Ltd.
- Kukje Pharmaceutical Industry Co., Ltd.
- RaQualia Pharma Inc.
- Sequella, Inc.
- Sihuan Pharmaceutical Holdings Group Ltd.
- Sinil Pharmaceutical Co., Ltd
- Yooyoung Pharmaceutical Co., Ltd
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Peptic Ulcers Treatment Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Peptic Ulcers Treatment Sales Estimates and Forecasts (2021-2032)
- 1.3 Peptic Ulcers Treatment Market by Type
- 1.3.1 DWP-14012
- 1.3.2 DWJ-206
- 1.3.3 BGC-001
- 1.3.4 ASP-6537
- 1.3.5 Others
- 1.4 Global Peptic Ulcers Treatment Market Size by Type
- 1.4.1 Global Peptic Ulcers Treatment Market Size Overview by Type (2021-2032)
- 1.4.2 Global Peptic Ulcers Treatment Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Peptic Ulcers Treatment Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Peptic Ulcers Treatment Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Peptic Ulcers Treatment Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Peptic Ulcers Treatment Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Peptic Ulcers Treatment Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Peptic Ulcers Treatment Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Peptic Ulcers Treatment Industry Trends
- 2.2 Peptic Ulcers Treatment Industry Drivers
- 2.3 Peptic Ulcers Treatment Industry Opportunities and Challenges
- 2.4 Peptic Ulcers Treatment Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Peptic Ulcers Treatment Revenue (2021-2026)
- 3.2 Global Top Players by Peptic Ulcers Treatment Sales (2021-2026)
- 3.3 Global Top Players by Peptic Ulcers Treatment Price (2021-2026)
- 3.4 Global Peptic Ulcers Treatment Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Peptic Ulcers Treatment Major Company Production Sites & Headquarters
- 3.6 Global Peptic Ulcers Treatment Company, Product Type & Application
- 3.7 Global Peptic Ulcers Treatment Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Peptic Ulcers Treatment Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Peptic Ulcers Treatment Players Market Share by Revenue in 2025
- 3.8.3 2025 Peptic Ulcers Treatment Tier 1, Tier 2, and Tier 3
4 Peptic Ulcers Treatment Regional Status and Outlook
- 4.1 Global Peptic Ulcers Treatment Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Peptic Ulcers Treatment Historic Market Size by Region
- 4.2.1 Global Peptic Ulcers Treatment Sales in Volume by Region (2021-2026)
- 4.2.2 Global Peptic Ulcers Treatment Sales in Value by Region (2021-2026)
- 4.2.3 Global Peptic Ulcers Treatment Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Peptic Ulcers Treatment Forecasted Market Size by Region
- 4.3.1 Global Peptic Ulcers Treatment Sales in Volume by Region (2027-2032)
- 4.3.2 Global Peptic Ulcers Treatment Sales in Value by Region (2027-2032)
- 4.3.3 Global Peptic Ulcers Treatment Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Peptic Ulcers Treatment by Application
- 5.1 Peptic Ulcers Treatment Market by Application
- 5.1.1 Hospital
- 5.1.2 Clinic
- 5.1.3 Others
- 5.2 Global Peptic Ulcers Treatment Market Size by Application
- 5.2.1 Global Peptic Ulcers Treatment Market Size Overview by Application (2021-2032)
- 5.2.2 Global Peptic Ulcers Treatment Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Peptic Ulcers Treatment Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Peptic Ulcers Treatment Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Peptic Ulcers Treatment Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Peptic Ulcers Treatment Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Peptic Ulcers Treatment Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Peptic Ulcers Treatment Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Ache Laboratorios Farmaceuticos S/A
- 6.1.1 Ache Laboratorios Farmaceuticos S/A Company Information
- 6.1.2 Ache Laboratorios Farmaceuticos S/A Business Overview
- 6.1.3 Ache Laboratorios Farmaceuticos S/A Peptic Ulcers Treatment Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Ache Laboratorios Farmaceuticos S/A Peptic Ulcers Treatment Product Portfolio
- 6.1.5 Ache Laboratorios Farmaceuticos S/A Recent Developments
- 6.2 Astellas Pharma Inc.
- 6.2.1 Astellas Pharma Inc. Company Information
- 6.2.2 Astellas Pharma Inc. Business Overview
- 6.2.3 Astellas Pharma Inc. Peptic Ulcers Treatment Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Astellas Pharma Inc. Peptic Ulcers Treatment Product Portfolio
- 6.2.5 Astellas Pharma Inc. Recent Developments
- 6.3 ChoDang Pharm Co., Ltd.
- 6.3.1 ChoDang Pharm Co., Ltd. Company Information
- 6.3.2 ChoDang Pharm Co., Ltd. Business Overview
- 6.3.3 ChoDang Pharm Co., Ltd. Peptic Ulcers Treatment Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 ChoDang Pharm Co., Ltd. Peptic Ulcers Treatment Product Portfolio
- 6.3.5 ChoDang Pharm Co., Ltd. Recent Developments
- 6.4 Daewoong Pharmaceutical Co., Ltd.
- 6.4.1 Daewoong Pharmaceutical Co., Ltd. Company Information
- 6.4.2 Daewoong Pharmaceutical Co., Ltd. Business Overview
- 6.4.3 Daewoong Pharmaceutical Co., Ltd. Peptic Ulcers Treatment Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 Daewoong Pharmaceutical Co., Ltd. Peptic Ulcers Treatment Product Portfolio
- 6.4.5 Daewoong Pharmaceutical Co., Ltd. Recent Developments
- 6.5 Kukje Pharmaceutical Industry Co., Ltd.
- 6.5.1 Kukje Pharmaceutical Industry Co., Ltd. Company Information
- 6.5.2 Kukje Pharmaceutical Industry Co., Ltd. Business Overview
- 6.5.3 Kukje Pharmaceutical Industry Co., Ltd. Peptic Ulcers Treatment Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 Kukje Pharmaceutical Industry Co., Ltd. Peptic Ulcers Treatment Product Portfolio
- 6.5.5 Kukje Pharmaceutical Industry Co., Ltd. Recent Developments
- 6.6 RaQualia Pharma Inc.
- 6.6.1 RaQualia Pharma Inc. Company Information
- 6.6.2 RaQualia Pharma Inc. Business Overview
- 6.6.3 RaQualia Pharma Inc. Peptic Ulcers Treatment Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 RaQualia Pharma Inc. Peptic Ulcers Treatment Product Portfolio
- 6.6.5 RaQualia Pharma Inc. Recent Developments
- 6.7 Sequella, Inc.
- 6.7.1 Sequella, Inc. Company Information
- 6.7.2 Sequella, Inc. Business Overview
- 6.7.3 Sequella, Inc. Peptic Ulcers Treatment Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 Sequella, Inc. Peptic Ulcers Treatment Product Portfolio
- 6.7.5 Sequella, Inc. Recent Developments
- 6.8 Sihuan Pharmaceutical Holdings Group Ltd.
- 6.8.1 Sihuan Pharmaceutical Holdings Group Ltd. Company Information
- 6.8.2 Sihuan Pharmaceutical Holdings Group Ltd. Business Overview
- 6.8.3 Sihuan Pharmaceutical Holdings Group Ltd. Peptic Ulcers Treatment Sales, Revenue and Gross Margin (2021-2026)
- 6.8.4 Sihuan Pharmaceutical Holdings Group Ltd. Peptic Ulcers Treatment Product Portfolio
- 6.8.5 Sihuan Pharmaceutical Holdings Group Ltd. Recent Developments
- 6.9 Sinil Pharmaceutical Co., Ltd
- 6.9.1 Sinil Pharmaceutical Co., Ltd Company Information
- 6.9.2 Sinil Pharmaceutical Co., Ltd Business Overview
- 6.9.3 Sinil Pharmaceutical Co., Ltd Peptic Ulcers Treatment Sales, Revenue and Gross Margin (2021-2026)
- 6.9.4 Sinil Pharmaceutical Co., Ltd Peptic Ulcers Treatment Product Portfolio
- 6.9.5 Sinil Pharmaceutical Co., Ltd Recent Developments
- 6.10 Yooyoung Pharmaceutical Co., Ltd
- 6.10.1 Yooyoung Pharmaceutical Co., Ltd Company Information
- 6.10.2 Yooyoung Pharmaceutical Co., Ltd Business Overview
- 6.10.3 Yooyoung Pharmaceutical Co., Ltd Peptic Ulcers Treatment Sales, Revenue and Gross Margin (2021-2026)
- 6.10.4 Yooyoung Pharmaceutical Co., Ltd Peptic Ulcers Treatment Product Portfolio
- 6.10.5 Yooyoung Pharmaceutical Co., Ltd Recent Developments
7 North America by Country
- 7.1 North America Peptic Ulcers Treatment Sales by Country
- 7.1.1 North America Peptic Ulcers Treatment Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Peptic Ulcers Treatment Sales by Country (2021-2026)
- 7.1.3 North America Peptic Ulcers Treatment Sales Forecast by Country (2027-2032)
- 7.2 North America Peptic Ulcers Treatment Market Size by Country
- 7.2.1 North America Peptic Ulcers Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Peptic Ulcers Treatment Market Size by Country (2021-2026)
- 7.2.3 North America Peptic Ulcers Treatment Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Peptic Ulcers Treatment Sales by Country
- 8.1.1 Europe Peptic Ulcers Treatment Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Peptic Ulcers Treatment Sales by Country (2021-2026)
- 8.1.3 Europe Peptic Ulcers Treatment Sales Forecast by Country (2027-2032)
- 8.2 Europe Peptic Ulcers Treatment Market Size by Country
- 8.2.1 Europe Peptic Ulcers Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Peptic Ulcers Treatment Market Size by Country (2021-2026)
- 8.2.3 Europe Peptic Ulcers Treatment Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Peptic Ulcers Treatment Sales by Country
- 9.1.1 Asia-Pacific Peptic Ulcers Treatment Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Peptic Ulcers Treatment Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Peptic Ulcers Treatment Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Peptic Ulcers Treatment Market Size by Country
- 9.2.1 Asia-Pacific Peptic Ulcers Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Peptic Ulcers Treatment Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Peptic Ulcers Treatment Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Peptic Ulcers Treatment Sales by Country
- 10.1.1 South America Peptic Ulcers Treatment Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Peptic Ulcers Treatment Sales by Country (2021-2026)
- 10.1.3 South America Peptic Ulcers Treatment Sales Forecast by Country (2027-2032)
- 10.2 South America Peptic Ulcers Treatment Market Size by Country
- 10.2.1 South America Peptic Ulcers Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Peptic Ulcers Treatment Market Size by Country (2021-2026)
- 10.2.3 South America Peptic Ulcers Treatment Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Peptic Ulcers Treatment Sales by Country
- 11.1.1 Middle East and Africa Peptic Ulcers Treatment Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Peptic Ulcers Treatment Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Peptic Ulcers Treatment Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Peptic Ulcers Treatment Market Size by Country
- 11.2.1 Middle East and Africa Peptic Ulcers Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Peptic Ulcers Treatment Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Peptic Ulcers Treatment Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Peptic Ulcers Treatment Value Chain Analysis
- 12.1.1 Peptic Ulcers Treatment Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Peptic Ulcers Treatment Production Mode & Process
- 12.2 Peptic Ulcers Treatment Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Peptic Ulcers Treatment Distributors
- 12.2.3 Peptic Ulcers Treatment Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst